Posted on 7/29/19
Ziopharm Oncology Announces $45 Million Warrant Exercise by Existing Shareholders in a Private Placement
BOSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that it has entered into an agreement with existing investors for the . . .
Posted on 7/29/19
Philanthropist Tej Kohli Pledges $2 Million Gift to Champion Biotech Solutions
LONDON & BOSTON--(BUSINESS WIRE)--Tej Kohli, a London-based billionaire who made his fortune during the dotcom boom selling e-commerce payments software, has pledged $2 million to Massachusetts . . .
Posted on 7/29/19
Karyopharm Therapeutics: Avoid In July 2019
SummarySafety profile of XPOVIO is not satisfactory.The primary endpoint in the STORM trial is weak and the measured efficacy benefit is also modest.Certain other risks also . . .
Posted on 7/29/19
Dynatrace Proposes Terms For U.S. IPO
Summary Dynatrace has filed proposed terms for its $427 million IPO.The firm sells IT monitoring software and services to enterprises.DT is growing moderately, has a heavy . . .
Posted on 7/28/19
Ra Pharmaceuticals Closes Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq: RARX) today announced the closing of an underwritten public offering of 4,600,000 shares of its common stock, at a public . . .
Posted on 7/28/19
Chiasma Prices Underwritten Public Offering of $55M of Common Stock
WALTHAM, Mass., July 26, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (Nasdaq: CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and . . .
Posted on 7/28/19
Solid Biosciences Announces $60M Private Placement
CAMBRIDGE, Mass., July 26, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) today announced that it has entered into a securities purchase agreement with a . . .
Posted on 7/26/19
Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors
CAMBRIDGE, Mass., July 26, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) today announced that it has entered into a securities purchase agreement with a . . .
Posted on 7/26/19
THQ: Buy This Fund Before Healthcare Sector Rebound
SummaryTHQ is a fund that focuses on investments in the healthcare sector.The fund sports a distribution rate of 7.64%, well above its ETF equivalent XLV with . . .
Posted on 7/26/19
Cara Therapeutics Proposes Offering of Common Stock
STAMFORD, Conn., July 24, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed . . .
Posted on 7/26/19
Verastem Oncology Signs an Exclusive License Agreement with Sanofi
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ: VSTM) operating as Verastem Oncology, today announced their entry into an exclusive licensing agreement with Sanofi to develop and commercialize Verastem Oncology’s . . .
Posted on 7/25/19
Genocea Provides Corporate Update
CAMBRIDGE, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today reported its operating and financial . . .
Posted on 7/25/19
Massachusetts General Hospital and ElevateBio Announce a 10-Year Alliance Agreement
BOSTON & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Massachusetts General Hospital (MGH) and ElevateBio, a cell and gene therapy holding company, today announced that they have entered into a 10-year . . .
Posted on 7/25/19
Alexion Pharmaceuticals Tops Expectations in Q2
Alexion Pharmaceuticals (NASDAQ:ALXN) gave investors a lot to like when it announced its first-quarter results in April. Revenue increased by 23% year over year, while adjusted . . .
Posted on 7/25/19
Biogen Raises Guidance as It Looks to the Pipeline for Growth
Biogen (NASDAQ:BIIB) put up relatively impressive sales numbers in the second quarter, with earnings per share growing like gangbusters as the drugmaker cut expenses and repurchased . . .
Posted on 7/24/19
Mevion and RaySearch Extend Collaboration
LITTLETON, Mass.--(BUSINESS WIRE)--Mevion and RaySearch’s collaborative partnership enabled the layer-by-layer collimation with the Adaptive Aperture pMLC as part of the RayStation 8B release, leading to the . . .
Posted on 7/24/19
Boston Scientific Announces Results For Second Quarter 2019
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.631 billion during the second quarter of 2019. This represents growth of 5.6 percent on a reported basis, . . .
Posted on 7/24/19
Thermo Fisher Scientific Reports Second Quarter 2019 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 29, 2019.Second Quarter . . .
Posted on 7/24/19
Alexion Reports Second Quarter 2019 Results
BOSTON--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the second quarter of 2019. Total revenues in the second quarter were $1,203.3 million, a 15 . . .
Posted on 7/24/19
Biogen Inc. 2019 Q2 - Results - Earnings Call Slides
The following slide deck was published by Biogen Inc. in conjunction with their 2019 Q2 earnings call.Download PDFREAD FULL ARTICLE HERE
Posted on 7/24/19
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q2 2019 Results - Earnings Call Transcript
Biogen Inc. (NASDAQ:BIIB) Q2 2019 Results Earnings Conference Call July 23, 2019 8:00 AM ETCompany ParticipantsMichel Vounatsos - Chief Executive OfficerJoe Mara - Vice President and . . .
Posted on 7/24/19
Is Vertex Pharmaceuticals a Buy?
Vertex Pharmaceuticals (NASDAQ:VRTX) stock has been trading sideways for the past year despite a string of positive developments most drugmakers can only dream of. Recently, the . . .
Posted on 7/24/19
Ra Pharmaceuticals Prices Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq: RARX) today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock, at a public . . .
Posted on 7/23/19
Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corp.
CAMBRIDGE, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 7/23/19
Blue Cross Blue Shield of Massachusetts Named A Best Place to Work For Disability Inclusion
Blue Cross Blue Shield of Massachusetts was recognized as a "Best Place to Work" for disability inclusion by the Disability Equality Index. A joint initiative of . . .

